Get the Stockscreener App
55.55
2.06%
1.12
After Hours:
55.55
Ultragenyx Pharmaceutical Inc Stock (RARE) Forecast
The Ultragenyx Pharmaceutical Inc (RARE) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $20.65, representing a -62.82% decrease from the current price of $55.55. The highest analyst price target is $24.32, and the lowest is $16.98.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RARE Price Target
Average 42.79
(-22.97% Downside)
Is Ultragenyx Pharmaceutical Inc (RARE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.74 | Neutral |
| STOCH(9,6) | 20.49 | Neutral |
| STOCHRSI(14) | 18.94 | Buy |
| MACD(12,26) | 0.6428 | Sell |
| ADX(14) | 33.21 | Sell |
| William %R | -72.81 | Neutral |
| CCI(14) | -122.52 | Sell |
Buy: 1
Sell: 3
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
57.07
Sell
|
56.46
Sell
|
| MA20 |
56.90
Sell
|
56.37
Sell
|
| MA50 |
53.26
Buy
|
53.49
Buy
|
| MA100 |
47.25
Buy
|
50.15
Buy
|
| MA200 |
46.95
Buy
|
47.11
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, RARE could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on RARE, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 48.74 indicates that RARE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 20.49 indicates that RARE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 18.94 indicates that RARE is oversold. This suggests that RARE price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.21 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -122.52 indicates that RARE is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term RARE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Ultragenyx Pharmaceutical Inc financial reports and earnings history, Ultragenyx Pharmaceutical Inc (RARE) stock could reach $23.34 by 2030, $6.4498 by 2040 and $15.12 by 2050. See the projected annual prices until 2050 of the Ultragenyx Pharmaceutical Inc stock below:
- Ultragenyx Pharmaceutical Inc (RARE) is expected to reach an average price of $10.17 in 2035, with a high prediction of $11.53 and a low estimate of $3.6245. This indicates an $-81.69% rise from the last recorded price of $55.55.
- Ultragenyx Pharmaceutical Inc (RARE) stock is projected to chart a bullish course in 2040, with an average price target of $2.0466, representing an $-96.32% surge from its current level. The forecast ranges from a conservative $4.3566 to a sky-high $6.4498.
- Our analysts predict Ultragenyx Pharmaceutical Inc (RARE) to jump -53.27% by 2045, soaring from $19.40 to an average price of $25.96, potentially reaching $20.98. While $19.40 is the low estimate, the potential upside is significant.
- Ultragenyx Pharmaceutical Inc (RARE) stock is expected to climb by 2050, reaching an average of $13.74, a $-75.26% jump from its current level. However, a wide range of estimates exists, with high and low targets of $15.12 and $18.01, respectively, highlighting the market's uncertainty.
Ultragenyx Pharmaceutical Inc Stock (RARE) Year by Year Forecast
Ultragenyx Pharmaceutical Inc Stock (RARE) Price Forecast for 2024
Our forecast for RARE stock price in 2024 now indicates an average price target of $35.13 with a high forecast of $54.56 and a low forecast of $15.71. The average prediction reflects an decrease of -36.75% from the last recorded price of $55.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2024 | $19.19 | $16.98 | $24.32 | -65.45% |
| December, 2024 | $23.43 | $15.71 | $23.97 | -57.82% |
Ultragenyx Pharmaceutical Inc Stock (RARE) Price Forecast for 2025
Ultragenyx Pharmaceutical Inc Stock (RARE) is expected to reach an average price of $48.18 in 2025, with a high prediction of $83.66 and a low estimate of $12.69. This indicates an -13.27% fall from the last recorded price of $55.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $23.64 | $21.25 | $26.44 | -57.44% |
| February, 2025 | $33.17 | $22.52 | $44.41 | -40.28% |
| March, 2025 | $34.41 | $31.35 | $44.85 | -38.05% |
| April, 2025 | $24.09 | $12.69 | $38.40 | -56.63% |
| May, 2025 | $43.87 | $23.26 | $45.44 | -21.02% |
| June, 2025 | $52.21 | $37.98 | $52.23 | -6.01% |
| July, 2025 | $58.48 | $46.30 | $58.53 | +5.28% |
| August, 2025 | $67.38 | $53.51 | $72.89 | +21.30% |
| September, 2025 | $66.05 | $56.31 | $71.35 | +18.90% |
| October, 2025 | $57.13 | $54.64 | $72.17 | +2.84% |
| November, 2025 | $63.60 | $54.17 | $68.12 | +14.49% |
| December, 2025 | $82.02 | $63.86 | $83.66 | +47.65% |
Ultragenyx Pharmaceutical Inc Stock (RARE) Price Forecast for 2026
The predicted value for Ultragenyx Pharmaceutical Inc (RARE) in 2026 is set at an average of $110.31. Estimates vary from a peak of $161.37 to a trough of $59.25, indicating an +98.57% surge from the present price of $55.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $104.03 | $72.71 | $105.97 | +87.27% |
| February, 2026 | $149.74 | $96.80 | $150.09 | +169.55% |
| March, 2026 | $119.76 | $113.60 | $161.37 | +115.58% |
| April, 2026 | $130.04 | $112.05 | $156.87 | +134.09% |
| May, 2026 | $106.72 | $92.60 | $130.58 | +92.11% |
| June, 2026 | $85.55 | $83.22 | $108.28 | +54.01% |
| July, 2026 | $93.07 | $81.71 | $101.70 | +67.53% |
| August, 2026 | $83.98 | $74.20 | $97.46 | +51.19% |
| September, 2026 | $73.73 | $70.05 | $87.80 | +32.72% |
| October, 2026 | $70.97 | $59.25 | $75.70 | +27.77% |
| November, 2026 | $78.85 | $59.88 | $80.53 | +41.95% |
| December, 2026 | $72.80 | $68.70 | $86.99 | +31.06% |
Ultragenyx Pharmaceutical Inc Stock (RARE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Ultragenyx Pharmaceutical Inc (RARE) is $50.58, with a high forecast of $72.42 and a low forecast of $28.74. This indicates an -8.95% decrease from the last price of $55.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $61.18 | $58.59 | $72.42 | +10.14% |
| February, 2027 | $62.17 | $58.56 | $72.37 | +11.92% |
| March, 2027 | $67.81 | $55.79 | $69.40 | +22.08% |
| April, 2027 | $55.10 | $51.25 | $71.20 | -0.81% |
| May, 2027 | $51.76 | $45.47 | $56.14 | -6.82% |
| June, 2027 | $46.03 | $45.38 | $62.88 | -17.14% |
| July, 2027 | $55.96 | $44.50 | $56.96 | +0.74% |
| August, 2027 | $58.49 | $55.83 | $68.94 | +5.29% |
| September, 2027 | $32.18 | $28.74 | $59.84 | -42.07% |
| October, 2027 | $36.92 | $28.99 | $38.79 | -33.54% |
| November, 2027 | $49.86 | $37.10 | $50.06 | -10.25% |
| December, 2027 | $35.40 | $32.86 | $52.42 | -36.28% |
Ultragenyx Pharmaceutical Inc Stock (RARE) Price Forecast for 2028
In 2028, Ultragenyx Pharmaceutical Inc (RARE) is projected to reach an average price of $28.73, with a high projection of $39.90 and a low estimate of $17.57. This indicates an -48.28% fall from the last price of $55.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $31.67 | $30.18 | $37.44 | -42.99% |
| February, 2028 | $25.42 | $23.56 | $33.94 | -54.25% |
| March, 2028 | $24.58 | $20.77 | $27.41 | -55.76% |
| April, 2028 | $19.93 | $17.57 | $26.94 | -64.13% |
| May, 2028 | $27.84 | $19.01 | $30.52 | -49.89% |
| June, 2028 | $26.81 | $23.55 | $32.74 | -51.74% |
| July, 2028 | $28.49 | $26.34 | $32.42 | -48.70% |
| August, 2028 | $23.37 | $22.38 | $33.83 | -57.94% |
| September, 2028 | $24.30 | $20.37 | $26.68 | -56.25% |
| October, 2028 | $32.00 | $21.92 | $34.02 | -42.39% |
| November, 2028 | $35.74 | $30.98 | $37.00 | -35.65% |
| December, 2028 | $31.11 | $31.08 | $39.90 | -43.99% |
Ultragenyx Pharmaceutical Inc Stock (RARE) Price Forecast for 2029
The 2029 price forecast for Ultragenyx Pharmaceutical Inc Stock (RARE) is $28.69 on average, with a high prediction of $40.45 and a low estimate of $16.93. This represents an -48.35% decrease from the previous price of $55.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $28.21 | $26.12 | $32.09 | -49.21% |
| February, 2029 | $23.09 | $19.49 | $28.39 | -58.43% |
| March, 2029 | $22.95 | $21.21 | $27.25 | -58.68% |
| April, 2029 | $18.93 | $17.37 | $23.73 | -65.92% |
| May, 2029 | $20.36 | $16.93 | $25.44 | -63.35% |
| June, 2029 | $25.72 | $19.55 | $26.04 | -53.70% |
| July, 2029 | $33.47 | $25.01 | $35.58 | -39.75% |
| August, 2029 | $29.87 | $27.59 | $35.48 | -46.23% |
| September, 2029 | $35.33 | $28.04 | $36.07 | -36.40% |
| October, 2029 | $31.81 | $31.52 | $40.45 | -42.74% |
| November, 2029 | $28.42 | $27.12 | $38.59 | -48.84% |
| December, 2029 | $22.91 | $19.58 | $31.65 | -58.76% |
Ultragenyx Pharmaceutical Inc Stock (RARE) Price Forecast for 2030
Ultragenyx Pharmaceutical Inc Stock (RARE) is expected to reach an average price of $12.74 in 2030, with a high forecast of $25.46 and a low forecast of $0.0134. This signifies an -77.07% decrease from the last price of $55.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $17.02 | $13.81 | $23.34 | -69.37% |
| February, 2030 | $18.10 | $15.26 | $24.62 | -67.42% |
| March, 2030 | $16.00 | $15.83 | $23.73 | -71.20% |
| April, 2030 | $14.33 | $10.29 | $23.57 | -74.20% |
| May, 2030 | $3.1669 | $1.5725 | $14.82 | -94.30% |
| June, 2030 | $1.3146 | $0.1346 | $5.6258 | -97.63% |
| July, 2030 | $0.6484 | $0.0134 | $2.749 | -98.83% |
| August, 2030 | $4.2592 | $0.7746 | $6.7642 | -92.33% |
| September, 2030 | $15.27 | $2.3374 | $19.49 | -72.51% |
| October, 2030 | $22.19 | $12.12 | $25.41 | -60.06% |
| November, 2030 | $0.4315 | $1.8485 | $25.46 | -99.22% |
| December, 2030 | $9.3391 | $2.3247 | $11.53 | -83.19% |
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):